Drawing for S SALTS HEALTHCARE

USPTO serial 79243444

S SALTS HEALTHCARE

Reviewed by CopyMark Law Group

Reg. 5899529Status 706Registered
Filing date
Status date
Registration date
Nov 5, 2019
Examiner
VO, JULIE
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with S SALTS HEALTHCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pina Campagna

Pina Campagna Carter, DeLuca, & Farrell, LLP576 Broad Hollow RoadMelville, NY 11747United States

Goods and services

ClassDescriptionStatusFirst use
005[ surgical dressings; ] adhesive materials for medical purposes in the nature of self-adhesive dressings; [adhesive patches in the nature of bandages for medical purposes; adhesives for use with ostomy appliances in the nature of medical adhesive tape;] adhesive plasters for medical purposes for use with ostomy appliances; adhesive tapes for medical purposes; adhesive removers adapted for medical use; [dressings,] pre-moistened medicated tissues and antiseptic wipes for medical purposes; [bandages for dressings; hygienic bandages for dressings; ] disinfectants; incontinence products, namely, incontinence garments in the nature of underwear; air deodorants, adapted for medical useACTIVE—
010Ostomy apparatus and dressings, namely, ostomy flanges used with pouching systems; ostomy bags and pouches; colostomy, urostomy and ileostomy bags and pouches; ostomy seals, flanges and rings for medical use; ostomy flange extender for medical purposes; filters and clips specially adapted for ostomy bags and pouches; stoma caps and collars; mouldable ostomy seals for medical purposes; support clothing specially adapted to wear with ostomy bags and pouches for medical use; support bandages for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 1, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 11, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 11, 202671AGREGISTERED-SEC.71 ACCEPTED—
Feb 9, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 16, 2025ES71TEAS SECTION 71 RECEIVED—
Nov 5, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 20, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 27, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 27, 2020FIMPFINAL DISPOSITION PROCESSED—
Feb 5, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 5, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 20, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 20, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 16, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jul 31, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 31, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 31, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 18, 2019ALIEASSIGNED TO LIE—
Jul 18, 2019ALIEASSIGNED TO LIE—
Jul 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 19, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jun 19, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 19, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 19, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 3, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 3, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 3, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 3, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2018RFNTREFUSAL PROCESSED BY IB—
Nov 17, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 17, 2018RFRRREFUSAL PROCESSED BY MPU—
Nov 8, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 7, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 23, 2018DOCKASSIGNED TO EXAMINER—
Oct 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 18, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance